Themis Bioscience GmbH
- Country
- 🇦🇹Austria
- Ownership
- Subsidiary
- Established
- 2009-09-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.themisbio.com
A Safety Study of TMV-018 in Patients With Tumors of the Gastrointestinal Tract
- Conditions
- Gastrointestinal Cancer
- Interventions
- Biological: TMV-018 + 5-FCBiological: TMV-018 + 5-FC + anti-PD-1Biological: TMV-018 + anti-PD-1
- First Posted Date
- 2019-12-11
- Last Posted Date
- 2020-11-25
- Lead Sponsor
- Themis Bioscience GmbH
- Registration Number
- NCT04195373
- Locations
- 🇩🇪
University Hospital Tübingen, Tübingen, Germany
🇩🇪University Hospital Bonn, Bonn, Germany
A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001)
- Conditions
- Lassa Virus Infection
- Interventions
- Biological: MV-LASVOther: Placebo
- First Posted Date
- 2019-08-13
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- Themis Bioscience GmbH
- Target Recruit Count
- 60
- Registration Number
- NCT04055454
- Locations
- 🇧🇪
University of Antwerpen, Centre for the Evaluation of Vaccination (CEV), Antwerp, Belgium
Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)
- Conditions
- Zika Virus Infection
- Interventions
- Biological: Two MV-ZIKA-RSP vaccination (low dose)Other: Two placebo injectionBiological: Two MV-ZIKA-RSP vaccinations (high dose)Biological: One MV-ZIKA-RSP vaccination (high dose) and one placebo
- First Posted Date
- 2019-07-25
- Last Posted Date
- 2021-12-06
- Lead Sponsor
- Themis Bioscience GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT04033068
- Locations
- 🇦🇹
Institute of Specific Prophylaxis and Tropical Medicine, Vienna, Austria
Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)
- Conditions
- Chikungunya Virus Infection
- Interventions
- Biological: V184Other: Placebo
- First Posted Date
- 2019-01-17
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- Themis Bioscience GmbH
- Target Recruit Count
- 41
- Registration Number
- NCT03807843
- Locations
- 🇵🇷
San Juan Hospital, Research Unit, San Juan, Puerto Rico
Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)
- Conditions
- Chikungunya Virus Infection
- Interventions
- Biological: MV-CHIK liquid frozen formulation, low doseBiological: MV-CHIK liquid frozen formulation, high doseBiological: MV-CHIK SPS® formulation, low doseBiological: MV-CHIK lyophilised formulation, low doseOther: Placebo
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- Themis Bioscience GmbH
- Target Recruit Count
- 60
- Registration Number
- NCT03635086
- Locations
- 🇬🇧
Celerion Belfast, Belfast, Northern Ireland, United Kingdom
Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic Area
- Conditions
- Chikungunya
- Interventions
- Biological: MMR-vaccineBiological: MV-CHIK
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2021-07-19
- Lead Sponsor
- Themis Bioscience GmbH
- Target Recruit Count
- 34
- Registration Number
- NCT03101111
- Locations
- 🇵🇷
University of Puerto Rico - Medical Sciences Campus, San Juan, Puerto Rico
Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)
- Conditions
- Zika Virus
- Interventions
- Biological: MV-ZIKAOther: Placebo
- First Posted Date
- 2016-12-19
- Last Posted Date
- 2022-08-18
- Lead Sponsor
- Themis Bioscience GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT02996890
- Locations
- 🇦🇹
Medical University of Vienna, Center for Pathophysiology, Infectiology and Immunology, Vienna, Austria
🇦🇹Medical University of Vienna, Department of Clinical Pharmacology, Vienna, Austria
Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine
- Conditions
- Chikungunya Virus Infection
- Interventions
- Biological: Priorix®Biological: MV-CHIK high doseBiological: MV-CHIK low doseBiological: physiological saline solution
- First Posted Date
- 2016-08-10
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Themis Bioscience GmbH
- Target Recruit Count
- 263
- Registration Number
- NCT02861586
- Locations
- 🇩🇪
Medicinal University Rostock, Department for Tropical Medicin and infectious diseases, Rostock, Germany
🇦🇹Hansa Sanatorium GmbH, Graz, Austria
🇩🇪Berliner Center for Travel- and Tropical Medicine, Berlin, Germany